ArticleFrontiers in pharmacology2026

Integrating multi-omics approaches reveals metabolic reprogramming and identifies PDHX as a candidate node in triptolide-treated non-small Cell lung cancer.

Quancheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.